Sotera Health Company SHC
16.05 USD -0.20 (-1.23%)
Regular-session close
16.05 0.00 0.00%
After hours · Nov 17, 4:01 PM ET
15.97 Day range 16.36
13.09 52-week range 19.85
- YTD
- -9.01%
- 1 year
- +5.18%
Benzinga news
benzinga.com David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes DME Capital Management reveals its new third-quarter stock picks. Here's what David Einhorn has been buying.benzinga.com JP Morgan Maintains Underweight on Sotera Health, Lowers Price Target to $15 JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Underweight and lowers the price target from $17 to $15.
benzinga.com Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $20 Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $22 to $20.
benzinga.com Sotera Health Q3 2026 Earnings Call Transcript Sotera Health (NASDAQ:SHC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…benzinga.com Sotera Health Q3 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $324.886M Beat $319.774M Estimate Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.27 by 7.41 percent. This is a 11.54 percent increase over earnings of $0.26…
benzinga.com Sotera Health Affirms FY2026 Adj EPS Guidance of $0.95-$1.01 vs $0.98 Est; Lowers FY2026 Sales Guidance from $1.236B-$1.254B to $1.233B-$1.250B vs $1.247B Est Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.95-$1.01 to $0.95-$1.01 vs $0.98 analyst estimate. Lowers FY2026 sales outlook from $1.236 billion-$1.254 billion to $1.233…
